NYLIM
CLB icon

New York Life Investment Management’s Core Laboratories CLB Stock Holding History

New York Life Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,934
Closed -$364K – 1235
2022
Q4 		$364K Buy
17,934
+2,022
+13% +$39.2K ﹤0.01% 1080
2022
Q3 		$214K Buy
15,912
+1,168
+8% +$19.7K ﹤0.01% 1176
2022
Q2 		$292K Buy
+14,744
New +$392K ﹤0.01% 1161

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

New York Life Investment Management's CLB Position: Q1 2023 in Review

New York Life Investment Management sold out of Core Laboratories (CLB) in Q1 2023, closing a stake of 17,934 shares — an estimated $364K sold.

New York Life Investment Management first reported a position in CLB in Q2 2022 and held it in 3 quarters. The position peaked at $364K in Q4 2022. 163 funds tracked by Wall St. Rank hold CLB as of Q1 2023.

  • New York Life Investment Management reported no remaining Core Laboratories position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 17,934 Core Laboratories shares in Q1 2023, an estimated $364K.
  • New York Life Investment Management first reported a position in Core Laboratories in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Core Laboratories position peaked at $364K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.